ZCM
VRTX icon

Ziegler Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Ziegler Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6.32M Sell
15,121
-341
-2% -$144K 0.24% 139
2023
Q4 		$6.29M Sell
15,462
-656
-4% -$242K 0.29% 78
2023
Q3 		$5.6M Buy
16,118
+1,208
+8% +$422K 0.22% 153
2023
Q2 		$5.25M Buy
+14,910
New +$5.02M 0.2% 166

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Ziegler Capital Management's VRTX Position: Q1 2024 in Review

Ziegler Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q1 2024, selling an estimated $144K and leaving 15,121 shares worth $6.32M. The position accounts for 0.24% of the portfolio, ranked #139.

Ziegler Capital Management first reported a position in VRTX in Q2 2023 and has held it in 4 quarters since. 1,494 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • Ziegler Capital Management held 15,121 shares of Vertex Pharmaceuticals worth $6.32M as of Q1 2024.
  • Ziegler Capital Management sold 341 Vertex Pharmaceuticals shares in Q1 2024, an estimated $144K.
  • Vertex Pharmaceuticals made up 0.24% of Ziegler Capital Management's portfolio in Q1 2024, its #139 holding.
  • Ziegler Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
  • 1,494 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.